An atrial fibrillation (AFib) diagnosis changes how you think about everyday choices—including what's in your glass. AFib affects an estimated 10.55 million American adults, according to a 2024 UCSF study published with the National Heart, Lung, and Blood Institute, and that number is projected to rise significantly as the population ages. For the millions newly diagnosed each year, the question is urgent: which beverages genuinely increase the risk of palpitations, recurrence, or stroke—and which warnings are overstated?

This article distills the clinical evidence behind five categories of drinks that matter for AFib patients. Rather than a blanket “avoid everything” list, we present what randomized trials, meta-analyses, and major guidelines actually say—including one finding that may surprise you.

1. Alcohol: The Strongest Evidence for Avoidance
Recommendation: Avoid or strictly limit.
Alcohol is the best-studied AFib trigger, and the data are unambiguous. The landmark HOLIDAY Monitors study (Marcus et al., Annals of Internal Medicine, 2021) equipped 100 paroxysmal AFib patients with continuous ECG monitors and found that a single alcoholic drink doubled the odds of an AFib episode within the following four hours. The risk increased with each additional drink.
More critically, the randomized controlled trial by Voskoboinik et al. (New England Journal of Medicine, 2020) showed that AFib patients who abstained from alcohol reduced their recurrence risk by 45% (HR 0.55, 95% CI 0.36–0.84). The absolute difference was striking: 53% of the abstinence group experienced recurrence vs. 73% of the control group over six months. Even drinking 1–9 drinks per week doubled the recurrence risk compared to complete abstinence (HR 2.1).
What the 2023 ACC/AHA Guideline says: The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation recommends lifestyle modification including alcohol reduction as a Class 1 recommendation for AFib management. The guideline emphasizes that alcohol cessation is one of the most effective non-pharmacologic interventions.
Practical takeaway: Complete abstinence produces the strongest benefit. If that is not sustainable, limit to no more than 1–2 drinks per week and monitor symptoms. The social trade-off is real, but the NEJM data show the cardiac benefit is real too.

2. Caffeine and Coffee: The Evidence Has Shifted
Recommendation: Moderate consumption (1 cup/day) appears safe and may be beneficial. Avoid excessive intake.
This is where the evidence has changed most dramatically. For decades, patients were told to avoid caffeine because it could “trigger” palpitations. But the highest-quality evidence now tells a different story.
The DECAF Randomized Clinical Trial (JAMA, November 2025): This open-label RCT enrolled coffee-drinking patients with persistent AFib after successful cardioversion and randomly assigned them to consume caffeinated coffee (averaging 1 cup/day) or to abstain completely. The result: AFib or atrial flutter recurred in 47% of the coffee group vs. 64% of the abstinence group—a 39% lower hazard of recurrence (HR 0.61). This is the first randomized trial to test coffee in AFib patients, and it found that moderate coffee consumption was associated with less recurrence, not more.
2026 Meta-Analysis (Aimaierjiang et al., Pacing Clin Electrophysiology): A systematic review of 9 cohort studies encompassing over 704,000 participants found that daily coffee consumption of 1 cup or less was associated with a 4% reduction in new-onset AFib risk (RR 0.96, 95% CI 0.93–0.99). Higher consumption levels (up to 5+ cups/day) showed no increased risk. The conclusion: coffee does not increase AFib risk and may offer mild protection at low doses.
What this means for you: If you already drink 1 cup of coffee a day and it does not cause symptoms, there is no evidence-based reason to stop. If you consume 4+ cups daily or feel palpitations after caffeine, consider reducing to moderate levels. Individual sensitivity varies—use your symptom log, not blanket fear.

3. Energy Drinks: Avoid Entirely
Recommendation: Avoid completely.
Energy drinks combine multiple AFib risk factors in a single serving: high caffeine (80–300 mg per can), additional stimulants (guarana, taurine, ginseng), and often large amounts of sugar. Case reports published in Cureus and other journals document AFib episodes in young adults with no prior cardiac history following energy drink consumption—including a 22-year-old male who consumed two bottles and developed AF requiring emergency care (Hanif & Saleem, 2020).
Why energy drinks are uniquely risky: Unlike coffee, which has decades of safety data and now even a randomized trial showing benefit, energy drinks have no long-term cardiac safety data in AFib patients. The combination of high-dose caffeine plus stimulants that have not been studied for cardiac safety makes them an unacceptable risk. The 2023 ACC/AHA Guideline does not address energy drinks specifically, but the precautionary principle applies.

4. Sugary and Artificially Sweetened Beverages
Recommendation: Limit or avoid. Replace with water or unsweetened alternatives.
A prospective cohort study of 201,856 UK Biobank participants (Wang et al., Circulation: Arrhythmia and Electrophysiology, 2024) tracked beverage consumption and AFib incidence over nearly 10 years. The findings:
Sugar-sweetened beverages (SSB): Consuming ≥2 liters per week (≈ six 12-oz cans) was associated with a 10% higher risk of incident AFib. Among current smokers, this rose to 31%.
Artificially sweetened beverages (ASB): Consuming ≥2 liters per week was associated with a 20% higher risk—roughly double the risk of sugar-sweetened drinks. This finding was independent of genetic AFib susceptibility.
Pure fruit juice (≤1 liter/week): Associated with an 8% lower risk, likely due to vitamins and polyphenols rather than the sugar content.
Mechanism: High sugar intake promotes inflammation, weight gain, and insulin resistance—all independent risk factors for AFib progression. The artificial sweetener finding is less well understood but may involve gut microbiome alterations and metabolic responses to non-nutritive sweeteners (sucralose, aspartame, saccharin, acesulfame).

5. High-Sodium Beverages and Electrolyte Disruption
Recommendation: Check labels; avoid beverages with >200 mg sodium per serving.
Sodium disrupts the electrolyte balance essential for normal cardiac conduction. A 2024 cohort study in JAMA Network Open found that higher daily sodium intake was associated with increased risk of incident AFib in patients with vascular disease. The 2024 European Heart Journal systematic review on diet and AFib confirmed that dietary sodium reduction is a key modifiable risk factor.
Hidden sodium sources:
Sports drinks: 200–400 mg sodium per bottle
Vegetable juices (including Bloody Mary mix): 400–600 mg per 8 oz
Bottled smoothies with added electrolytes: 150–300 mg
Canned soups consumed as beverages: 700–1,000 mg per cup
The blood pressure connection: Sodium-induced hypertension is one of the most consistent AFib risk factors. If you consume high-sodium drinks regularly, you may be undermining your blood pressure medication—potentially requiring higher doses and exposing yourself to additional side effects. The DASH eating pattern, which emphasizes low sodium, has been shown to improve blood pressure control and may reduce AFib burden.

At a Glance: The Evidence for Each Beverage
Beverage Level of Evidence Recommendation Key Study
Alcohol RCT + Case-crossover Avoid or strictly limit NEJM 2020: HR 0.55
Ann Intern Med 2021
Coffee (moderate) RCT + Meta-analysis Safe at ≤1 cup/day JAMA DECAF 2025: HR 0.61
Meta-analysis 2026
Energy drinks Case reports Avoid entirely Cureus 2020 case series
Sugary/ASB drinks Prospective cohort Limit; ≤2 L/week risky AHA Circ: AEP 2024
High-sodium drinks Cohort + diet review Check labels; <200 mg JAMA Netw Open 2024 Eur Heart J 2024 Building Your Personal Beverage Strategy AFib is heterogeneous. What triggers one patient's palpitations may be irrelevant to another. The key is systematic self-monitoring, not fear-based avoidance. Step-by-step approach Week 1–2: Baseline. Keep a simple beverage and symptom diary. Note every drink and any palpitations, shortness of breath, fatigue, or irregular rhythm. Use a smartphone app or a notebook—consistency matters more than format. Week 3–4: Eliminate the clear hits. Remove alcohol and energy drinks entirely. These have the strongest evidence for harm. Monitor your symptom frequency. The NEJM trial showed that benefit from alcohol elimination is measurable within weeks. Week 5–6: Adjust caffeine. If you drink >3 cups of coffee daily, reduce to 1–2. Note: the DECAF trial data suggest no need to eliminate coffee entirely if you tolerate it well. But if palpitations persist, try switching to decaf temporarily.
Ongoing: Read labels for sugar and sodium. Check nutrition facts panels for hidden sodium and sugar content in sports drinks, juices, and “wellness” beverages. The UK Biobank data suggest that this habit alone may lower your long-term AFib risk.

When to Contact Your Cardiologist
If you experience palpitations lasting more than a few minutes, chest pain, severe shortness of breath, dizziness, or fainting, seek immediate medical attention. Do not rely on lifestyle changes alone to manage acute symptoms.
Discuss your beverage consumption openly with your cardiologist or electrophysiologist. The 2023 ACC/AHA Guideline emphasizes shared decision-making: your doctor needs to know what you drink to help you build a sustainable plan. A referral to a registered dietitian with cardiac experience may also be valuable.

Sources
Voskoboinik A et al. “Alcohol Abstinence in Drinkers with Atrial Fibrillation.” New England Journal of Medicine. 2020;382:20–28. doi:10.1056/NEJMoa1817591
Marcus GM et al. “Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events.” Annals of Internal Medicine. 2021. doi:10.7326/M21-0228
DECAF Trial. “Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation.” JAMA. Published online November 9, 2025. doi:10.1001/jama.2025.21056
Aimaierjiang N et al. “Is Coffee Consumption Associated With Increased Risk of Atrial Fibrillation? A Systematic Review and Meta-Analysis.” Pacing Clin Electrophysiology. 2026.
Wang N et al. “Sweetened Beverages, Genetic Susceptibility, and Incident Atrial Fibrillation.” Circulation: Arrhythmia and Electrophysiology. 2024. doi:10.1161/CIRCEP.123.012145
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. Circulation. 2023. doi:10.1161/CIR.0000000000001193
UCSF/NHLBI. “Atrial Fibrillation Estimated to Affect About 1 in 22 Americans.” September 2024.
Hanif M, Saleem S. “Energy Drinks and Atrial Fibrillation: An Unusual Case of Caution.” Cureus. 2020. doi:10.7759/cureus.10816
Johnson LS et al. “Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease.” JAMA Network Open. 2024.
European Heart Journal. “Diet and Risk of Atrial Fibrillation: A Systematic Review.” 2024;45(40):4259.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Atrial fibrillation is a serious medical condition that requires individualized care from a qualified healthcare provider. Do not make changes to your medication, diet, or lifestyle based on this article without consulting your cardiologist or electrophysiologist. If you are experiencing chest pain, severe shortness of breath, or fainting, call 911 or your local emergency number immediately.

By